AngioDynamics | ANGO - Cost Of Sales


AngioDynamics reported $37.29M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 37.29M 786K Sep/2025
Artivion USD 42.85M 3.86M Dec/2025
AtriCure USD 31.94M 3.22M Mar/2026
Boston Scientific USD 1.83B 8M Mar/2026
Edwards Lifesciences USD 362.6M 19.6M Mar/2026
ICU Medical USD 337.72M 1.61M Dec/2025
Inogen USD 39.59M 1.27M Sep/2024
J&J USD 8.07B 103M Mar/2026
Medtronic USD 3.8B 195M Mar/2026
Merit Medical Systems USD 197.08M 1.5M Mar/2026
Mesa Laboratories USD 21.92M 1.78M Sep/2024
Orthofix International USD 66.63M 6.4M Dec/2025
Smiths GBP 544M 494M Jun/2026
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Teleflex USD 240.84M 20.7M Mar/2026
Terumo JPY 151.3B 7.86B Mar/2026
Trinity Biotech USD 7.84M 3.14M Sep/2025